5T4 oncofoetal antigen: an attractive target for immune intervention in cancer Peter L. SternRichard Harrop Review 18 October 2016 Pages: 415 - 426
Intratumoral Th2 predisposition combines with an increased Th1 functional phenotype in clinical response to intravesical BCG in bladder cancer Renate PichlerGeorg GruenbacherMartin Thurnher Original Article Open access 22 December 2016 Pages: 427 - 440
Combined treatment with ipilimumab and intratumoral interleukin-2 in pretreated patients with stage IV melanoma—safety and efficacy in a phase II study Benjamin WeideAlexander MartensClaus Garbe Original Article 22 December 2016 Pages: 441 - 449
Delivery of foreign cytotoxic T lymphocyte epitopes to tumor tissues for effective antitumor immunotherapy against pre-established solid tumors in mice Herbert W. KavunjaShuyao LangXuefei Huang Original Article 23 December 2016 Pages: 451 - 460
The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients Ana ColadoMaría Belén AlmejúnMercedes Borge Original Article 23 December 2016 Pages: 461 - 473
Development of T cells carrying two complementary chimeric antigen receptors against glypican-3 and asialoglycoprotein receptor 1 for the treatment of hepatocellular carcinoma Cheng ChenKesang LiZonghai Li Original Article 29 December 2016 Pages: 475 - 489
Synergistic effects of host B7-H4 deficiency and gemcitabine treatment on tumor regression and anti-tumor T cell immunity in a mouse model Joanne LeungPhilippe St-OngeWoong-Kyung Suh Original Article 10 January 2017 Pages: 491 - 502
Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients Kimberly R. JordanPuja KapoorMartin D. McCarter Original Article 20 January 2017 Pages: 503 - 513
Inclusion of BLIMP-1+ effector regulatory T cells improves the Immunoscore in a cohort of New Zealand colorectal cancer patients: a pilot study Kirsten A. Ward-HartstongeJohn L. McCallRoslyn A. Kemp Original Article 23 January 2017 Pages: 515 - 522
Regulation of PD-L1 expression on murine tumor-associated monocytes and macrophages by locally produced TNF-α Genevieve HartleyDaniel ReganSteven Dow Original Article 09 February 2017 Pages: 523 - 535
Augmented anti-tumor activity of NK-92 cells expressing chimeric receptors of TGF-βR II and NKG2D Zhongjuan WangLinghua GuoHaiyan Liu Original Article 09 February 2017 Pages: 537 - 548
In memory of Professor Enrico Mihich: Editor-in-Chief of Cancer Immunology, Immunotherapy 1982–2012 Graham PawelecSuzanne Ostrand-Rosenberg Obituary 11 March 2017 Pages: 549 - 549